Harel Insurance Investments & Financial Services’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.65M | Sell |
|
|||||
|
2025
Q2 | $2.16M | Sell |
|
|||||
|
2025
Q1 | $4.14M | Sell |
|
|||||
|
2024
Q4 | $4.93M | Hold |
|
|||||
|
2024
Q3 | $5.88M | Sell |
|
|||||
|
2024
Q2 | $7.78M | Sell |
|
|||||
|
2024
Q1 | $10.1M | Sell |
|
|||||
|
2023
Q4 | $13.1M | Sell |
|
|||||
|
2023
Q3 | $12.2M | Sell |
|
|||||
|
2023
Q2 | $10.6M | Sell |
|
|||||
|
2023
Q1 | $9.48M | Buy |
|
|||||
|
2022
Q4 | $9.1M | Sell |
|
|||||
|
2022
Q3 | $8.53M | Sell |
|
|||||
|
2022
Q2 | $8.4M | Sell |
|
|||||
|
2022
Q1 | $8.93M | Sell |
|
|||||
|
2021
Q4 | $9.75M | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $108K | Buy |
|
|||||
|
2019
Q1 | $74K | Buy |
|
|||||
|
2018
Q4 | $43K | Sell |
|
|||||
|
2018
Q3 | $123K | Hold |
|
|||||
|
2018
Q2 | $129K | Buy |
|